FENC250117C7500
- 0.20
- 0.000.00%
Fennec Pharmaceuticals Newsroom
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating
Craig-Hallum Initiates Fennec Pharmaceuticals(FENC.US) With Buy Rating
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating
H.C. Wainwright Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $13
Fennec Pharmaceuticals Analyst Ratings
Stephens Initiates Fennec Pharmaceuticals(FENC.US) With Buy Rating, Announces Target Price $15
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Cuts Target Price to $15
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Announces Target Price $12
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Cuts Target Price to $15
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating
Craig-Hallum Initiates Fennec Pharmaceuticals(FENC.US) With Buy Rating
Craig-Hallum Remains a Buy on Fennec Pharmaceuticals (FENC)
Fennec Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for Fennec Pharmaceuticals Amidst PEDMARK's Long-Term Growth Potential
H.C. Wainwright Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Cuts Target Price to $13
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $22
Buy Rating for Fennec Pharmaceuticals Bolstered by Pedmark's Market Expansion and New Leadership
Fennec Pharmaceuticals Analyst Ratings
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Announces Target Price $15